Literature DB >> 2370310

Blind comparison of Abbott and Dupont HIV antigen ELISA tests for detecting antigenaemia in asymptomatic human immunodeficiency virus antibody positive homosexual men.

D C Shanson1, K E Brown, S Goonesekera, B Gazzard, A R Coates.   

Abstract

Three hundred and ninety eight serum samples from 270 human immunodeficiency virus (HIV) antibody positive asymptomatic homosexual men were tested in the Abbott and Dupont HIV antigen ELISA tests. In the Abbott test 62 (16%) of the sera were positive, according to the manufacturer's instructions, compared with 55 (14%) in the Dupont test. Twenty six sera were positive with the Abbott test but negative with the Dupont test and 19 sera were positive only by the Dupont test. Only 36 (9%) of the sera were positive in both tests. The Abbott confirmatory neutralisation test gave excellent agreement with the initial Abbott HIV antigen ELISA test; the Dupont confirmatory test was only in agreement with the initial positive Dupont antigen ELISA test in one third of the sera tested. Although the overall sensitivity of each of the two commercial assays tested was similar, the Abbott method may be preferable for clinical purposes if confirmation of an initial ELISA positive test result by neutralisation assay is required.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2370310      PMCID: PMC502455          DOI: 10.1136/jcp.43.5.420

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.

Authors:  J M Lange; D A Paul; H G Huisman; F de Wolf; H van den Berg; R A Coutinho; S A Danner; J van der Noordaa; J Goudsmit
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

2.  Clinical importance of HIV antigen and anti-HIV core markers in persons infected with HIV.

Authors:  P N Lelie; H W Reesink; E Bakker; J G Huisman; J H ten Veen
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

3.  Human immunodeficiency virus antigenemia in patients with AIDS and AIDS-related disorders: a comparison between European and Central African populations.

Authors:  A Baillou; F Barin; J P Allain; E Petat; P Kocheleff; P Kadende; A Goudeau
Journal:  J Infect Dis       Date:  1987-11       Impact factor: 5.226

4.  Significant changes in HIV antigen level in the serum of patients treated with azidothymidine.

Authors:  R E Chaisson; J P Allain; M Leuther; P A Volberding
Journal:  N Engl J Med       Date:  1986-12-18       Impact factor: 91.245

5.  Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection.

Authors:  C Pedersen; C M Nielsen; B F Vestergaard; J Gerstoft; K Krogsgaard; J O Nielsen
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-05

Review 6.  Antigen detection for human immunodeficiency virus.

Authors:  D J Harry; M B Jennings; J Yee; J R Carlson
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

7.  Correlation of enzyme-linked immunosorbent assays for serum human immunodeficiency virus antigen and antibodies to recombinant viral proteins with subsequent clinical outcomes in a cohort of asymptomatic homosexual men.

Authors:  K H Mayer; L A Falk; D A Paul; G J Dawson; A M Stoddard; J McCusker; S P Saltzman; M W Moon; R Ferriani; J E Groopman
Journal:  Am J Med       Date:  1987-08       Impact factor: 4.965

8.  Effect of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects.

Authors:  F de Wolf; J M Lange; J Goudsmit; P Cload; J de Gans; P T Schellekens; R A Coutinho; A P Fiddian; J van der Noordaa
Journal:  Lancet       Date:  1988-02-20       Impact factor: 79.321

9.  Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection.

Authors:  J Goudsmit; F de Wolf; D A Paul; L G Epstein; J M Lange; W J Krone; H Speelman; E C Wolters; J Van der Noordaa; J M Oleske
Journal:  Lancet       Date:  1986-07-26       Impact factor: 79.321

10.  Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT).

Authors:  G G Jackson; D A Paul; L A Falk; M Rubenis; J C Despotes; D Mack; M Knigge; E E Emeson
Journal:  Ann Intern Med       Date:  1988-02       Impact factor: 25.391

View more
  1 in total

1.  Molecular specificity of two commercial enzyme linked immunosorbent assays for human immunodeficiency virus antigens.

Authors:  K E Brown; D C Shanson; P Mascagni; A R Coates
Journal:  J Clin Pathol       Date:  1991-12       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.